Jushi Holdings (JUSHF) Change in Accured Expenses (2021 - 2026)
Jushi Holdings' (JUSHF) quarterly Change in Accured Expenses came in at $3.7 million in Q1 2026, down 36.27% year-on-year from $5.7 million in Q1 2025, and up 325.42% on a QoQ basis from -$1.6 million in Q4 2025.
Jushi Holdings (JUSHF) Change in Accured Expenses (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has 6 years of Change in Accured Expenses data on file, last reported at $3.7 million in Q1 2026.
- On a quarterly basis, Change in Accured Expenses fell 36.27% year-over-year to $3.7 million in Q1 2026; TTM through Mar 2026 was -$1.2 million, a 112.56% decrease from a year earlier, with the FY2025 full-year figure at $893000.0, down 90.93% from the prior year.
- Change in Accured Expenses for Q1 2026 stood at $3.7 million, up from -$1.6 million in the prior quarter.
- Over the last five years, Change in Accured Expenses for JUSHF reached as high as $10.8 million in Q4 2022 and fell as low as -$10.6 million in Q3 2023.
- Historically, Change in Accured Expenses has averaged $2.0 million across 5 years, with a median of $3.7 million in 2026.
- Across the five-year window, Change in Accured Expenses soared 437.66% in 2023 and slumped 1238.68% in 2025, its largest moves.
- Year by year, Change in Accured Expenses stood at $10.8 million in 2022, then tumbled by 117.74% to -$1.9 million in 2023, then soared by 128.88% to $553000.0 in 2024, then slumped by 393.85% to -$1.6 million in 2025, then surged by 325.42% to $3.7 million in 2026.
- Per Business Quant data, the three most recent Change in Accured Expenses figures were $3.7 million in Q1 2026, -$1.6 million in Q4 2025, and $5.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | -144.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -234.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -12.70 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | -14.30 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Jushi Holdings | 81.25 Mn | 41.54 Mn | 29.88 Mn | 3.66 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 3.66 Mn |
| Mar 31, 2026 | 3.66 Mn |
| Dec 31, 2025 | -1.63 Mn |
| Dec 31, 2025 | -1.63 Mn |
| Sep 30, 2025 | 5.28 Mn |
| Sep 30, 2025 | 5.28 Mn |
| Jun 30, 2025 | -8.51 Mn |
| Jun 30, 2025 | -8.51 Mn |
| Mar 31, 2025 | 5.75 Mn |
| Mar 31, 2025 | 5.75 Mn |
| Dec 31, 2024 | 553,000.00 |
| Dec 31, 2024 | 553,000.00 |
| Sep 30, 2024 | 3.83 Mn |
| Sep 30, 2024 | 3.83 Mn |
| Jun 30, 2024 | -636,000.00 |
| Jun 30, 2024 | -636,000.00 |
| Mar 31, 2024 | 6.10 Mn |
| Mar 31, 2024 | 6.10 Mn |
| Dec 31, 2023 | -1.92 Mn |
| Dec 31, 2023 | -1.92 Mn |